Department of Chemistry and the Ralph N. Adams Institute for Bioanalytical Chemistry, University of Kansas, Lawrence, KS, United States.
Analytical Research & Development Mass Spectrometry, Merck & Co., Inc., Kenilworth, NJ, USA.
J Pharm Sci. 2021 Jun;110(6):2355-2361. doi: 10.1016/j.xphs.2021.02.027. Epub 2021 Feb 25.
Affinity chromatography is widely used for antibody purification in biopharmaceutical production. Although there is evidence suggesting that affinity chromatography might induce structural changes in antibodies, allosteric changes in structure have not been well-explored. Here, we used hydrogen exchange-mass spectrometry (HX-MS) to reveal conformational changes in the NIST mAb upon binding with a protein A (ProA) matrix. HX-MS measurements of NIST mAb bound to in-solution and resin forms of ProA revealed regions of the C2 and C3 domains with increased protection from HX upon ProA binding, consistent with the known ProA binding region. In-solution ProA experiments revealed regions in the F with increased HX uptake when the ProA:mAb molar ratio was increased to 2:1, suggesting an allosterically induced increase in backbone flexibility. Such effects were not observed with lower ProA concentration (1:1 molar ratio) or when ProA resin was used, suggesting some kind of change in binding mode. Since all pharmaceutical processes use ProA bound to resin, our results rule out reversible allosteric effects on the NIST mAb during interaction with resin ProA. However, irreversible effects cannot be ruled out since the NIST mAb was previously exposed to ProA during its original purification.
亲和层析广泛应用于生物制药生产中的抗体纯化。虽然有证据表明亲和层析可能会导致抗体结构发生变化,但对结构的变构变化尚未进行充分探索。在这里,我们使用氢交换-质谱(HX-MS)来揭示 NIST mAb 与蛋白 A(ProA)基质结合时 C2 和 C3 结构域的构象变化。对结合在溶液中和树脂形式的 ProA 上的 NIST mAb 的 HX-MS 测量揭示了 C2 和 C3 结构域中与 ProA 结合时 HX 保护增加的区域,与已知的 ProA 结合区域一致。在溶液中的 ProA 实验中,当 ProA:mAb 摩尔比增加到 2:1 时,F 结构域中 HX 摄取增加的区域增加,这表明变构诱导的骨架灵活性增加。当使用较低的 ProA 浓度(1:1 摩尔比)或使用 ProA 树脂时,未观察到这种效应,这表明结合模式发生了某种变化。由于所有药物工艺都使用与树脂结合的 ProA,因此我们的结果排除了 NIST mAb 在与树脂 ProA 相互作用过程中可逆的变构效应。然而,由于 NIST mAb 之前在其原始纯化过程中暴露于 ProA,因此不能排除不可逆的影响。